Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Colchicine After Percutaneous Coronary Intervention
NCT06472908Phase 3Active, not recruiting
- Start
- Jul 2024
- Primary completion
- Jun 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in coronary heart disease (CHD). Started Jul 2024; status: active, not recruiting.
02
Drugs
colchicine
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT06472908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06472908.